PH-0113 Anti-Epidermal Growth Factor Receptor Therapy in combination with Chemoradiotherapy for the Treatment of Locally Advanced Anal Canal Carcinoma: Results of a Phase II Study with Panitumumab (FFCD 0904). (August 2021)

• Record Type: Journal Article
• Authors: Vendrely, V.; Ronchin, P.; Le-Malicot, K.; MINSAT, M.; Lemanski, C.; MIRABEL, X.; LIEVRE, A.; DARUTJOUVE, A.; DE LA Fouchardiere, C.; Breysacher, G.; Argo-Leignel, D.; Thimonier, E.; Magne, N.; Belletier, C.; Lepage, C.; Aparicio, T.
• Is Part Of: Radiotherapy and oncology. Volume 161(2021)supplement
• Page Start: S82
• Page End: S83
• Publication Date: 2021-08
• Subjects: Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/S0167-8140(21)07247-9
• Languages: English
• ISSNs: 0167-8140